A detailed history of Jane Street Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 1,314,499 shares of MRNA stock, worth $66.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,314,499
Previous 493,590 166.31%
Holding current value
$66.1 Million
Previous $52.6 Million 196.78%
% of portfolio
0.18%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $83.1 Million - $137 Million
820,909 Added 166.31%
1,314,499 $156 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $17.3 Million - $23.4 Million
-202,428 Reduced 29.08%
493,590 $52.6 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $23.3 Million - $34.9 Million
334,530 Added 92.54%
696,018 $69.2 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $4.69 Million - $6.17 Million
48,698 Added 15.57%
361,488 $37.3 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $88.2 Million - $119 Million
-744,200 Reduced 70.41%
312,790 $38 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $63.1 Million - $91.6 Million
464,961 Added 78.54%
1,056,990 $162 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $10.1 Million - $17.9 Million
85,189 Added 16.81%
592,029 $106 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $13.1 Million - $21.6 Million
111,046 Added 28.06%
506,840 $59.9 Million
Q2 2022

Aug 16, 2022

SELL
$117.13 - $176.59 $29 Million - $43.7 Million
-247,545 Reduced 38.48%
395,794 $56.5 Million
Q1 2022

May 17, 2022

SELL
$126.46 - $235.05 $88.1 Million - $164 Million
-696,531 Reduced 51.98%
643,339 $111 Million
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $199 Million - $324 Million
879,448 Added 191.01%
1,339,870 $340 Million
Q3 2021

Nov 16, 2021

SELL
$221.9 - $484.47 $96.5 Million - $211 Million
-434,998 Reduced 48.58%
460,422 $177 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $82.4 Million - $149 Million
633,932 Added 242.43%
895,420 $210 Million
Q1 2021

May 18, 2021

SELL
$109.18 - $185.98 $57 Million - $97.1 Million
-522,079 Reduced 66.63%
261,488 $34.2 Million
Q4 2020

Feb 17, 2021

SELL
$65.74 - $169.86 $44.2 Million - $114 Million
-672,772 Reduced 46.2%
783,567 $81.9 Million
Q3 2020

Nov 17, 2020

BUY
$54.34 - $94.85 $14.7 Million - $25.6 Million
270,147 Added 22.77%
1,456,339 $103 Million
Q2 2020

Aug 17, 2020

BUY
$29.67 - $80.0 $34.2 Million - $92.1 Million
1,151,727 Added 3341.73%
1,186,192 $76.2 Million
Q1 2020

May 15, 2020

SELL
$17.78 - $31.58 $497,644 - $883,892
-27,989 Reduced 44.82%
34,465 $1.03 Million
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $869,984 - $1.33 Million
62,454 New
62,454 $1.22 Million
Q1 2019

May 16, 2019

SELL
$14.45 - $23.7 $179,035 - $293,643
-12,390 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$13.52 - $18.8 $167,512 - $232,932
12,390 New
12,390 $189,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $19.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.